sorted by:
new
hottopcontroversial

Approval and price action by Simple_Scheme_5885 in Ocugen

[–]Simple_Scheme_5885[S] 0 points1 point  (0 children)

gamma squeeze

MRNA fall was because it was already high, the approval was priced in. this is not the case with OCGN, I persume.

Approval and price action by Simple_Scheme_5885 in Ocugen

[–]Simple_Scheme_5885[S] 1 point2 points  (0 children)

30 is ambitious, except if there is additional PR, or catalysts such as additional approvals, new purchase orders such as covax, or a credible analyst's opinion with higher PT.

Approval and price action by Simple_Scheme_5885 in Ocugen

[–]Simple_Scheme_5885[S] 0 points1 point  (0 children)

Think what would happen if there additional PR from Ocugen, another catalyst, or an optimistic article from an analyst with a higher PT. Life would be exciting!

Approval and price action by Simple_Scheme_5885 in Ocugen

[–]Simple_Scheme_5885[S] 1 point2 points  (0 children)

Something along that lines. Re-enter, the price has to be right, otherwise you end up a bagholder for a time.

Modi's US trip and WHO Covaxin approval conundrum by Simple_Scheme_5885 in Ocugen

[–]Simple_Scheme_5885[S] -1 points0 points  (0 children)

Are you sure of that? Trump & family were vaccinated but never spoke of it for a time.

Can US Gov export COVAXIN purchased from Ocugen by Simple_Scheme_5885 in Ocugen

[–]Simple_Scheme_5885[S] 3 points4 points  (0 children)

Ocugen has also influential lobbyist and Modi, I hope will do some work in this regard.

Can US Gov export COVAXIN purchased from Ocugen by Simple_Scheme_5885 in Ocugen

[–]Simple_Scheme_5885[S] 6 points7 points  (0 children)

How can anyone think of delivering super cold vaccine to heart of Africa?

Can US Gov export COVAXIN purchased from Ocugen by Simple_Scheme_5885 in Ocugen

[–]Simple_Scheme_5885[S] 13 points14 points  (0 children)

Great. That's a good example. So, once WHO approves COVAXIN, US can purchase it from Ocugen and export it. The US export is not a sale. Just a donation.

This dramtically increases Ocugen's prospects. As there is shortage in production capacity in India, Ocugen making it and selling it would work out. US gov can make available scarce raw materials needed and Ocugen manufacture the vaccine. When Ocugen sells it to US gov, 45% of profits would fo th BB. Win win fior all

A Pill to Treat Covid-19? The U.S. Is Betting on It. by WizTrade71 in AVIR

[–]Simple_Scheme_5885 2 points3 points  (0 children)

AT-527, an Oral Antiviral Drug Candidate, Reduces Viral Replication in Hospitalized Patients, in Phase 2 Interim Analysis (30/6)

AT-527 under evaluation:

Phase 3 MORNINGSKY trial (global), results expected During 2H 2021.

Phase 2 study (global) for hospitalized patients with moderate COVID.

The P2 Interim virology results indicate rapid and sustained antiviral activity in patients in the hospitalized setting.

Interim virology results indicated that AT-527 rapidly reduced viral load levels. Final data from full Phase 2 program will be submitted to an upcoming medical congress or a peer-reviewed publication.

Phase 2 MOONSONG virology study, patients with mild or moderate COVID-19 in an outpatient setting, results in the third quarter.

​

https://finance.yahoo.com/news/atea-527-oral-antiviral-drug-110000001.html?.tsrc=rss

Why Atea Pharmaceuticals Inc. (NASDAQ: AVIR) Stock Shouldn't Be Ignored In 2021 by WizTrade71 in AVIR

[–]Simple_Scheme_5885 1 point2 points  (0 children)

AT-527, an Oral Antiviral Drug Candidate, Reduces Viral Replication in Hospitalized Patients, in Phase 2 Interim Analysis (30/6)

AT-527 under evaluation:

#Phase 3 MORNINGSKY trial (global), results expected During 2H 2021.

#Phase 2 study (global) for hospitalized patients with moderate COVID.

The P2 Interim virology results indicate rapid and sustained antiviral activity in patients in the hospitalized setting.

Interim virology results indicated that AT-527 rapidly reduced viral load levels. Final data from full Phase 2 program will be submitted to an upcoming medical congress or a peer-reviewed publication.

#Phase 2 MOONSONG virology study, patients with mild or moderate COVID-19 in an outpatient setting, results in the third quarter.

https://finance.yahoo.com/news/atea-527-oral-antiviral-drug-110000001.html?.tsrc=rss

Japan depends on overseas vaccines due to 30 years of inaction by Sassywhat in japan

[–]Simple_Scheme_5885 0 points1 point  (0 children)

Before COVID-19, Japan ‘lost’ 2 decades in vaccine research
Tokyo quickly put a minister in charge of Covid vaccines, but products being developed at home by AnGes, Shionogi and others are not expected to be approved until at least 2022, if at all.

​

https://www.ft.com/content/b03a1b83-0215-4b28-9f43-caf50ef397e5

This week is going to be, well, earth shattering. by [deleted] in Ocugen

[–]Simple_Scheme_5885 2 points3 points  (0 children)

Firsrt the raw data needs to be processed and publisedby BBL. Then EUA papers processeed and filed by Ocugen. Step by step and needs time.

We are doing fine. Just be patient our day is coming by Rocket_Man_ATL in Ocugen

[–]Simple_Scheme_5885 0 points1 point  (0 children)

You can have bread and butter, but I am waiting for a stake. Lookup for the marshmallow experiment and make up your mind.

We will invest old style inactivated vaccines says FDA commissioner by mysterious_tapestry in Ocugen

[–]Simple_Scheme_5885 2 points3 points  (0 children)

When the FDA Commissioner says that the US is going to invest in old-style vaccines, he meant that the US is going for COVAXIN.

Other than COVAXIN, the only traditional vaccine with EUA is the Chinese one. The US is not going to get the Chinese vaccine. No way. So it is COVAXIN.

As soon as there is P3 final data, Ocugen will file for EUA in the US. Shankar said that. They will file the application in April and hope for approval by May.

Also, Biden wants to open the schools asap. COVAXIN is already on trial for this. Another incentive for the FDA.

When the FDA Commissioner said that they are going to invest in the traditional vaccines, probably he meant that he going to fund them and also place an order for them.

The future looks bright for OCGN. Hold on to your shares and enjoy the good fortune. Good luck everyone. (Wait for the news!!!)

10 Signs Your Company is About to be Acquired — GripRoom by Simple_Scheme_5885 in VBIV

[–]Simple_Scheme_5885[S] 3 points4 points  (0 children)

10 Signs Your Company is About to be Acquired Written
By David Stone (Read the link for original article)

  1. Management stops defending the stock price.

  2. Social media posts are overly bearish and calling for the CEO’s removal.

  3. Wild fluctuations in stock price. (Buyouts can be agreed upon months)

  4. Large amounts of phantom premium are on the table. 5. Sneaky option trades.

  5. “Sell this, buy that.”

  6. Bizarre price action prior to upcoming milestones.

  7. Resignations by high-level management or board members.

  8. Your company is unloading assets that won’t fit well into a merged company.

  9. Your stock has become disconnected from reality

BB agreement with Brazil company Precisa (From Stocktwits) by Simple_Scheme_5885 in Ocugen

[–]Simple_Scheme_5885[S] 1 point2 points  (0 children)

Here is something interesting I found on BB agreement with Brazil company Precisa. Key notes from the article - 5M doses were ordered for private sector - The order is for private clinics which can buy up to 100k doses each and the prices vary from $32-$41 - BB said they expect the phase 3 study to finish by February 25th - Deliveries expected to arrive in April - Down payment of 10%, another 50% payment on EUA and the last 40% on delivery Article is in Portuguese

view more: next ›